Welcome to Shanghai Probechem Biochemicals Co Ltd !Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : R992
Catalog No.: PC-49565Not For Human Use, Lab Use Only.
R992 (MERTK inhibitor) is a novel potent, selective and orally bioavailable inhibitor of Mer tyrosine kinase (MerTK) with IC50 of 18 nM in ADP-Glo assays.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
R992 (MERTK inhibitor) is a novel potent, selective and orally bioavailable inhibitor of Mer tyrosine kinase (MerTK) with IC50 of 18 nM in ADP-Glo assays.
R992 exhibits seven to eight-fold selectivity over AXL and TYRO3 in biochemical assays.
R992 docked in MERTK and the H-bonds R992 forms with three residues in the ATP pocket (MET-647, PRO-672, and ASP-741).
R992 blocks MERTK phosphorylation in HUVEC with EC50 of 32 nM, effectively blocks MERTK phosphorylation in human and murine cells.
R992 (60 mg/kg, orally 2x/day) dose-dependently increases bone nodule formation and increases osteoblast differentiation markers Alpl, SP7, and Runx2.
Treatment with R992 of osteoblasttumor cultures could decrease F-actin content, stress fiber formation, and promoted osteoblast spreading.
R992 inhibits multiple myeloma tumor progression and bone disease in U266 myeloma mouse models.
R992 inhibits tumor progression and cancer-induced bone loss in breast- and lung cancer bone metastasis in the lung- and breast cancer models.
| M.Wt | 478.641 | |
| Formula | C27H38N6O2 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Engelmann J, et al. Nat Commun. 2022 Dec 12;13(1):7689.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
